Anne Wojcicki

Anne Wojcicki CNBC Next 25
Benjamin Wachenje

Title: Co-founder and CEO, 23andMe

Born: July 28, 1973, San Mateo, California

Education: BS in biology, Yale University

Early Marker: Spent the last 10 years as a health-care investment analyst, focused mainly on biotech companies.

Big Idea: Named for the 23 pairs of chromosomes in a human cell, 23andMe sells personal genome-cell tests so individuals can explore their DNA. The FDA blocked the company's initial efforts to sell health-related reports that reveal a customer's health condition and genetic background, but the company recently gained approval to offer the service in Canada.

Wave of the Future: Genomics

Latest Special Reports

  • In a world of big box retail and e-commerce, successful business owners are taking new paths to Main Street success.

  • Covid-19 is expected to be with us for years even if the colossal investment in treatments and vaccines eventually manages to contain and control the global pandemic. The world will look dramatically different in its wake. As businesses begin the shift from crisis mode to planning for the lasting impact of Covid, CNBC’s journalists will hunt for cases of companies and industries taking a leading role in shaping Our New Future.

  • Traders and financial professionals work on the floor of the New York Stock Exchange.

    CNBC’s financial reporters weigh in on what every investor needs to know when it comes to companies' earnings reports.

CNBC25: Rebels, Icons and Leaders